Early Arena Pharma (ARNA) Volume Exceeds 1M Mark; Stock Continues Higher
Tweet
Share
E-mailGet Alerts ARNA Hot Sheet
Join SI Premium – FREE
Sentiment in Arena Pharmaceuticals (Nasdaq: ARNA) continues early Thursday. Ahead of the bell, over 1 million shares have already traded hands. The stock is also up about 1.4 percent.
Sentiment continues as Arena averts a PDUFA delay with just a handful of days left. In addition, shares could hit well above $15 each should it receive a favorable outcome.
Sentiment continues as Arena averts a PDUFA delay with just a handful of days left. In addition, shares could hit well above $15 each should it receive a favorable outcome.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump: Iran conflict is working out very well, talks going on at request of Iran
- Lucid Group stock surges 24% on Saudi prince investment
- Ferguson Enterprises to Join S&P 500; ADI Global Distribution to Join S&P SmallCap 600
Create E-mail Alert Related Categories
Insiders' Blog, Momentum Movers, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
